Late-stage, primary open-angle glaucoma in Europe: social and health care maintenance costs and quality of life of patients from 4 countries

By Thygesen J.   Aagren M.   Arnavielle S.   Bron A.   Fröhlich S. J.   Baggesen K.   Azuara-Blanco A.   Buchholz P.   Walt J. G.  

Current Medical Research and Opinion, Vol. 24, Iss. 6, 2008-06 ,pp. : 1763-1770

Informa Healthcare

Access to resources Recommend Favorite

Mixed treatment comparison and meta-regression of the efficacy and safety of prostaglandin analogues and comparators for primary open-angle glaucoma and ocular hypertension

By Orme M.   Collins S.   Dakin H.   Kelly S.   Loftus J.  

Current Medical Research and Opinion, Vol. 26, Iss. 3, 2010-03 ,pp. : 511-528

Informa Healthcare

Access to resources Recommend Favorite

LOXL1 gene and risk of open‐angle glaucoma

By  

CLINICAL & EXPERIMENTAL OPHTHALMOLOGY, Vol. 43, Iss. 1, 2015-01 ,pp. : 26-30

John Wiley & Sons Inc

Access to resources Recommend Favorite

Transporter Associated with Antigen Processing Gene 1 Codon 333 and Codon 637 Polymorphisms are Associated with Primary Open-Angle Glaucoma

By Lin Hui-Ju   Chang Hai Tsai   Tsai Fuu-Jen   Chen Wen-Chi  

Molecular Diagnosis, Vol. 8, Iss. 4, 2004-01 ,pp. : 245-252

Adis International

Access to resources Recommend Favorite

Ocular hypotensive efficacy and safety of travoprost 0.004% in inadequately controlled primary open-angle glaucoma or ocular hypertension: short-term, multicenter, prospective study

By Blini Mirella   Rossi Gemma Caterina Maria   Trabucchi Giuseppe   Curatola Maria R.   David Alessandro   Radaelli Rosella   Merlo Giancarlo   Ratiglia Roberto  

Current Medical Research and Opinion, Vol. 25, Iss. 1, 2009-01 ,pp. : 57-63

Informa Healthcare

Access to resources Recommend Favorite